Low credibility URL sharing on Twitter during reporting linking rare blood clots with the Oxford/AstraZeneca COVID-19 vaccine.
The COVID-19 pandemic was accompanied by an "infodemic" of misinformation. Misleading narratives around the virus, its origin, and treatments have had serious implications for public health. In March 2021, concerns were raised about links between the Oxford/AstraZeneca (AZ) COVID-19 vaccin...
Main Authors: | Ali Hobbs, Aisha Aldosery, Patty Kostkova |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0296444&type=printable |
Similar Items
-
Thromboembolism and the Oxford-AstraZeneca vaccine
by: Perera, R, et al.
Published: (2021) -
Malaysia to use AstraZeneca vaccine
by: Povera, Adib
Published: (2021) -
Membranoproliferative Glomerulonephritis following the Oxford AstraZeneca COVID-19 Vaccine
by: Kawtar Hassani, et al.
Published: (2021-01-01) -
Immunogenicity of Oxford-AstraZeneca COVID-19 vaccine in Vietnamese healthcare workers
by: Van Vinh Chau, N, et al.
Published: (2021) -
Busting the Breast Cancer with AstraZeneca’s Gefitinib
by: S. Chemmalar, et al.
Published: (2023-01-01)